Software and data-focused Vista Equity Partners has driven AI-enabled healthcare provider Olive’s valuation to $4bn to continue a massive funding surge for the business since the start of the Covid-19 pandemic.
The post Vista Equity Partners boosts Olive’s valuation to $4bn, a 1.6x increase in just six months first appeared on AltAssets Private Equity News.
